News

July 5^th , 2010 – BIOTOOLS announces that an agreement has been reached with the Paraná Molecular Biology Institute (IBMP), one of the main reference centers in Brazil, to create an epidemiological surveillance network

• Signed agreement includes transfer technology and expects to set‐up as many as 26 laboratories throughout Brazil, meeting the requirements of the Brazilian Ministry of Health

Biotools has recently reached an agreement with IBMP to create an epidemiological surveillance network for the Brazilian Health System, including diagnostics and production technology transfer.

Biotools will transfer its proprietary technologies, and will provide reagents and equipment needed to establish up to 26 laboratories until the end of agreement.

Biotools will also provide technical support for laboratory implementation as well as for their maintenance, enabling product development and solutions meeting particularities of Brazilian and South American epidemiology in general.

This agreement is part of the Strategic Plan of the Brazilian Health System for controlling health spending, and to achieve technological independence.

This way Biotools consolidates its business in Brazil, as in September 2009 also reached an agreement with the Brazilian Ministry of Health, implementing Biotools Technologies in a PCR‐based blood screening program for HIV and Hepatitis C (HCV) in the Brazilian Public Health System.

About Biotools B&M Labs, S.A.

Biotools is a leading Spanish company with a global presence in the development of biological reagents, equipment, and technologies supporting biomedicine, biotechnology, and life science research. The company collaborates with leading hospitals, universities, and research centers in Europe to develop molecular diagnostic solutions using Biotools’ proprietary technologies and patents.

About IBPM

IBMP –, an institution resulting from an association between Oswaldo Cruz Foundation – Fiocruz – and Office of Science, Technology and Higher Education to develop projects in the area of Molecular Biology aimed for human and animal health. The IBMP is one of the main reference centers in Brazil for the research and development of modern techniques of gene cloning and expression with DNA recombination methods.

Through agreements, IBMP develops activities of advising private and public entities that are interested in developing projects concerning human health and, when there is mutual interest, promotes the association of parties interested in the development of joint research projects. The Brazilian Ministry of Health, particularly the Department of Science, Technology and Strategic Inputs, supports this project.

Related Links:

http://portal.saude.gov.br/portal/aplicacoes/noticias/default.cfm?pg=dspDetalheNoticia&id_area=1450&CO_NOTICIA=11473

http://www.isaude.net/pt-BR/noticia/8505/saude-publica/brasil-lanca-tecnologia-desenvolvida-para-diagnosticar-virus-h1n1

http://www.conass.org.br/?id_area=28&pagina=dspDetalhes&COSEQ=8034